Comparison of Outcomes in Patients With Atrial Fibrillation Under Oral Anticoagulation Therapy Analyzed by Body Weight ( < 60, 60 to 100, and > 100 kg)
This study aimed to evaluate embolic, hemorrhagic, and mortality events in anticoagulated patients, administered both antivitamin K and direct oral anticoagulants based on the body weight (100 kg). A retrospective registry-based cohort study including all consecutive patients with a diagnosis of atrial fibrillation between January 2014 and January 2018 in the health area of Vigo (Galicia, Spain) was used (CardioCHUVI‐AF registry; ClinicalTrials.gov identifier: NCT04364516).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Pablo Dom ínguez-Erquicia, Sergio Raposeiras-Roubín, Emad Abu-Assi, Paula Bouzon-Iglesias, Jose A. Parada-Barcia, Andrea Lizancos-Castro, André González-García, Vanesa A. Noriega-Caro, Ana Ledo-Piñeiro, Carla Iglesias-Otero, Inmaculada González-Ber Source Type: research